Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030341 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis
A NA study of Diabetic Gastroparesis, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 7
- Study locations
NCT01030341: Completed NA study of Diabetic Gastroparesis, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT01030341 is a NA study of Diabetic Gastroparesis that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 45 participants, below the 155-participant average among 7 other Diabetic Gastroparesis trials with a reported enrollment target (71% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030341, a NA study of Diabetic Gastroparesis, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 7
- Study locations
Study Summary
A pilot study to assess the safety, feasibility, and potential (uncontrolled) efficacy of continuous glucose monitoring (CGMS) in conjunction with an insulin pump to improve glycemic control for treatment of type 1 and type 2 diabetic patients with gastroparesis
Primary Outcome
The incidence rate (events / person-week) of mild/moderate (glucose level \< 70 mg/dL) and severe (glucose \< 50 mg/dL) hypoglycemic episodes during screening vs 24 week of follow-up visits while using a combination of continuous glucose monitoring system (CGMS) and insulin pump therapy.
Conditions Studied
Interventions
- DEVICE CGMS and insulin pump
Study Locations (7)
California
- California Pacific Medical Center - San Francisco
- Stanford University - Stanford
Michigan
- University of Michigan Medical Center - Ann Arbor
Mississippi
- University of Mississippi Medical Center - Jackson
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Pennsylvania
- Temple University Hospital - Philadelphia
Texas
- Texas Tech University Health Sciences Center - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT01030341 record still lists
NCT01030341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 155-participant average among 7 other Diabetic Gastroparesis trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Diabetic Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which CGMS and insulin pump is the first listed.
NCT01030341 lists 7 locations in 6 states (California, Michigan, Mississippi).
Frequently Asked Questions
What is clinical trial NCT01030341 about?
NCT01030341 is a clinical study titled "Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis". A pilot study to assess the safety, feasibility, and potential (uncontrolled) efficacy of continuous glucose monitoring (CGMS) in conjunction with an insulin pump to improve glycemic control for treatment of type 1 and type 2 diabetic patients with gastroparesis
What is the current status of trial NCT01030341?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2011-05. Estimated completion is 2015-01.
What conditions does trial NCT01030341 study?
This clinical trial studies the following conditions: Diabetic Gastroparesis.
What interventions are being tested in trial NCT01030341?
The interventions under investigation include: CGMS and insulin pump (DEVICE).
Who is sponsoring clinical trial NCT01030341?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01030341 being conducted?
This trial has 7 study locations across California, Michigan, Mississippi, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
RECRUITING
-
Thoracic Neuromodulation for Diabetic Gastroparesis
RECRUITING · Phase 1
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
COMPLETED · Phase 2
-
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
COMPLETED · Phase 2
-
Biomagnetic Characterization of Gastric Dysrhythmias III
COMPLETED · Early Phase 1
-
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia